000 01563 a2200385 4500
005 20250516051714.0
264 0 _c20120305
008 201203s 0 0 eng d
022 _a1432-2277
024 7 _a10.1111/j.1432-2277.2011.01309.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBartel, Gregor
245 0 0 _aPrevention and treatment of alloantibody-mediated kidney transplant rejection.
_h[electronic resource]
260 _bTransplant international : official journal of the European Society for Organ Transplantation
_cDec 2011
300 _a1142-55 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntilymphocyte Serum
_xadverse effects
650 0 4 _aComplement Inactivating Agents
_xtherapeutic use
650 0 4 _aDesensitization, Immunologic
650 0 4 _aGraft Rejection
_ximmunology
650 0 4 _aHLA Antigens
_xblood
650 0 4 _aHistocompatibility Testing
650 0 4 _aHumans
650 0 4 _aImmunoglobulins, Intravenous
_xadministration & dosage
650 0 4 _aImmunosorbent Techniques
650 0 4 _aIsoantibodies
_xblood
650 0 4 _aKidney Transplantation
_xadverse effects
650 0 4 _aPlasmapheresis
650 0 4 _aProteasome Inhibitors
650 0 4 _aTissue Donors
700 1 _aSchwaiger, Elisabeth
700 1 _aBöhmig, Georg A
773 0 _tTransplant international : official journal of the European Society for Organ Transplantation
_gvol. 24
_gno. 12
_gp. 1142-55
856 4 0 _uhttps://doi.org/10.1111/j.1432-2277.2011.01309.x
_zAvailable from publisher's website
999 _c21075806
_d21075806